A Study to Learn How Different Amounts of the Study Medicine Called PF-06954522 Are Tolerated and Act in the Body of Healthy Adults

A Phase 1, Randomized, Double-Blind, Sponsor -Open, Placebo-Controlled, Crossover, First-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of PF-06954522 in Healthy Adult Participants